Benedikte J. Hasselbalch
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
The confounding effects of microvascular physiology on the uptake and diagnostic accuracy of [18F]fluoroethyl-tyrosine positron emission tomography in gliomas.
Journal: European journal of nuclear medicine and molecular imaging
Published: September 08, 2025
Identifying targetable alterations predictive of distant progression in glioblastoma patients undergoing standard therapy.
Journal: Neuro-oncology advances
Published: June 27, 2025
Spatial transcriptomic analysis reveals lack of response to PD-1 blockade in recurrent glioblastoma.
Spatial transcriptomic analysis reveals lack of response to PD-1 blockade in recurrent glioblastoma.
Journal: Acta neuropathologica
Published: June 06, 2025
Actionable alterations in glioblastoma: Insights from the implementation of genomic profiling as the standard of care from 2016 to 2023.
Journal: Neuro-oncology practice
Published: February 07, 2025
Added prognostic value of DCE blood volume imaging in patients with suspected recurrent or residual glioblastoma-A hybrid [18F]FET PET/MRI study.
Journal: Neuro-oncology advances
Published: December 12, 2024
Magnetic resonance imaging and o-(2-[18F]fluoroethyl)-l-tyrosine positron emission tomography for early response assessment of nivolumab and bevacizumab in patients with recurrent high-grade astrocytic glioma.
Journal: Neuro-oncology advances
Published: December 11, 2024
Degradation fragments of Tau and type IV collagen as serum biomarkers in patients with recurrent glioblastoma treated with nivolumab and bevacizumab.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: July 19, 2024
The Neurogenome study: Comprehensive molecular profiling to optimize treatment for Danish glioblastoma patients.
Journal: Neuro-oncology advances
Published: December 13, 2023
Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways.
Journal: Cancer immunology research
Published: November 14, 2023
Implementing targeted therapies in the treatment of glioblastoma: Previous shortcomings, future promises, and a multimodal strategy recommendation.
Journal: Neuro-oncology advances
Published: November 03, 2022
Diagnostic yield of simultaneous dynamic contrast-enhanced magnetic resonance perfusion measurements and [18F]FET PET in patients with suspected recurrent anaplastic astrocytoma and glioblastoma.
Journal: European journal of nuclear medicine and molecular imaging
Published: February 10, 2022
A Prognostic Model for Glioblastoma Patients Treated With Standard Therapy Based on a Prospective Cohort of Consecutive Non-Selected Patients From a Single Institution.
Journal: Frontiers in oncology
Published: August 21, 2020
Last Updated: 09/26/2026